Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating SPK-843 for pulmonary fungal infections including cryptococcosis and aspergillosis. The trial investigates efficacy, safety, and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Cryptococcosis

Drugs mentioned

• SPK-843 (SPK-843)

Snippet

Sponsor: Proaparts srl | Conditions: Cryptococcosis or Aspergillosis Infections | Phase 3 | Status: UNKNOWN